HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Innate Immunity

Innate immunity serves as the body's first line of defense against invading pathogens, providing a rapid and nonspecific response to potential threats. This crucial component of the immune system is present from birth and does not rely on prior exposure to specific pathogens. The skin and mucous membranes act as physical barriers, preventing the entry of microbes into the body. Additionally, various antimicrobial substances, such as enzymes and peptides, are present in bodily fluids, further inhibiting the growth and spread of pathogens. Phagocytic cells, including neutrophils and macrophages, play a pivotal role in innate immunity by engulfing and digesting foreign particles. These cells recognize common features shared by a broad range of pathogens, allowing for a swift response to infection. The complement system, consisting of proteins in the blood, enhances the immune response by promoting phagocytosis, triggering inflammation, and forming membrane attack complexes that can directly lyse pathogens. This system acts in coordination with other components of innate immunity to amplify the overall defense mechanisms. Innate immunity also includes natural killer (NK) cells, which target and destroy infected or abnormal cells, particularly those with altered surface markers. These cells contribute to the elimination of virus-infected cells and play a vital role in cancer surveillance. While innate immunity provides immediate protection, it also influences the adaptive immune response by signaling and activating specific immune cells. This collaboration ensures a comprehensive and effective defense against a wide range of pathogens, ultimately safeguarding the body from potential threats.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp